Pharmacists Voice Support for Compounding Medications

Published Online: Sunday, August 1, 2004

During the recent Compounders on Capitol Hill event, a legislative conference sponsored by the International Academy of Compounding Pharmacists (IACP), attendees met to discuss pharmacy issues. One issue was the recent FDA guidance that prohibits pharmacists and veterinarians from preparing custom medications from bulk drugs for companion animals.

For the last 10 years, compounding pharmacists have spoken on behalf of pharmacy compounding by meeting in Washington to educate legislators about the necessity of individualized medications. "Due to our members' efforts on the Hill this year, 48 Congressmen and 18 Senators signed on to sponsor the rescission of this fundamentally flawed guidance," said IACP Executive Director L.D. King. "We must let Congress know that our pet population will needlessly suffer if the present policy is adopted?."

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues